期刊
JOURNAL OF PSYCHIATRIC RESEARCH
卷 133, 期 -, 页码 73-81出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2020.12.011
关键词
Suicide; Major depressive disorder; Panic disorder; Tumor necrosis factor alpha; Interleukin-6
类别
资金
- National Research Foundation of Korea (NRF)
- Electronics and Telecommunications Research Institute (ETRI)
- Samsung Medical Center
- Sungkyunkwan University
- Institute for Information & communications Technology Promotion (IITP) - Korea government (MSIT) [2015-0-00062]
- National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2016M3C7A1947307]
- Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [NRF2017M3A9F1027323]
This study investigated the associations between serum inflammatory cytokine levels and suicidality in patients with major depressive disorder (MDD) and panic disorder (PD). Results suggest that MDD and PD patients may have significantly higher levels of inflammatory markers compared to healthy controls. Furthermore, higher baseline levels of TNF-alpha in MDD patients were found to be a significant predictor of changes in suicide ideation intensity.
Previous studies have investigated the role of inflammatory markers in suicidality of patients with major depressive disorder (MDD) or panic disorder (PD). However, few studies have investigated associations between serum inflammatory cytokine levels and suicidality. We hypothesized that MDD and PD status might be significantly associated with serum inflammatory cytokines and that we could predict levels of improvement in suicide ideation intensity using serum inflammatory biomarkers in patients with MDD and PD. For this study, 41 patients with MDD, 52 patients with PD, and 59 healthy control (HC) subjects were enrolled. Psychological measurements and serum inflammatory markers such as interleukin (IL)-6, -10, interferon (IFN)-gamma, tumor necrosis factor (TNE)-alpha, and C reactive protein (CRP) were examined. A total of five visits were completed during 12 weeks. After controlling for confounding factors, log-transformed IL-6 (ln_IL-6) at baseline (MDD: 0.297 +/- 0.626; PD: 0.342 +/- 0.723; HC: -0.121 +/- 0.858; p = 0.007, >0.0017, 0.05/30) and mean ln_IL-6 (MDD: 0.395 +/- 0.550, PD: 0.249 +/- 0.544, HC: -0.139 +/- 0.622, p = 0.002, >0.0017, 0.05/30) levels were trends towards significantly higher in patients with MDD and PD than in HC. In MDD patients, a higher level of basal ln_TNF-alpha was a significant predictor of Delta SSI (changes in SSI scores between baseline and week 12) even after controlling for changes of depression symptoms and baseline SSI scores (standardized beta = 0.541, p = 0.002 < 0.0028, 0.05/18). In conclusion, we could predict Delta SSI using baseline inflammatory biomarkers for patients with MDD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据